MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Acetazolamide

Acetazolamide 250mg tablets

No stability information

Stability notes for Acetazolamide 250mg tablets

There are no stability notes for this medicine.

Suppliers (11) of Acetazolamide 250mg tablets
Acetazolamide 250mg tablets (A A H Pharmaceuticals Ltd)
Acetazolamide 250mg tablets (Advanz Pharma)
Acetazolamide 250mg tablets (Alliance Healthcare (Distribution) Ltd)
Acetazolamide 250mg tablets (Blumont Pharma Ltd)
Acetazolamide 250mg tablets (Crescent Pharma Ltd)
Acetazolamide 250mg tablets (Drugsrus Ltd)
Acetazolamide 250mg tablets (Genesis Pharmaceuticals Ltd)
Acetazolamide 250mg tablets (Medihealth (Northern) Ltd)
Acetazolamide 250mg tablets (Morningside Healthcare Ltd)
Acetazolamide 250mg tablets (Phoenix Healthcare Distribution Ltd)
Acetazolamide 250mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.